Determination of alpha 1 -antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA

By Jung K.   Brux B.   Lein M.   Knabich A.   Sinha P.   Rudolph B.   Schnorr D.   Loening S.A.  

Urology, Vol. 53, Iss. 6, 1999-06 ,pp. : 1160-1167

Elsevier

Access to resources Recommend Favorite

Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasia

By Cadeddu J.A.   Pearson J.D.   Lee B.R.   Landis P.   Partin A.W.   Epstein J.I.   Carter H.B.  

Urology, Vol. 45, Iss. 5, 1995-05 ,pp. : 795-800

Elsevier

Access to resources Recommend Favorite

Are Neuroendocrine Cells Responsible for the Development of Benign Prostatic Hyperplasia?

By Manjurul Islam A.H.M.   Kato H.   Hayama M.   Kobayashi S.   Igawa Y.   Ota H.   Nishizawa O.  

European Urology, Vol. 42, Iss. 2, 2002-08 ,pp. : 79-83

Elsevier

Access to resources Recommend Favorite

Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting

By Keetch D.W.   Andriole G.L.   Ratliff T.L.   Catalona W.J.  

Urology, Vol. 50, Iss. 6, 1997-12 ,pp. : 901-905

Elsevier

Access to resources Recommend Favorite

Effects of Intercellular Adhesion Molecule-1 on Renal Damage in Spontaneously Hypertensive Rats

By Zhang Ding-Wu   Huang Xin-Zhong   Wu Jian-Hua   Fan Ya-Pin   Shi Hui  

Renal Failure, Vol. 34, Iss. 7, 2012-08 ,pp. : 915-920

Informa Healthcare

Access to resources Recommend Favorite